Key Highlights
- 12.71% is the pre-market decline indicated for Ainos, Inc. (NASDAQ:AIMD) on November 17, 2026, with shares indicated at USD 1.00 against a calculated prior close of USD 1.1456.
- 7.38 million shares were outstanding in the latest published data, implying a calculated market Capitalization of about USD 7.38 million at the indicated pre-market price of USD 1.00 per share.
- 642,889 USD was third quarter 2026 revenue, compared with USD 2,167 a year earlier, while trailing Revenue of USD 654,322 compares with a trailing net loss of USD 13.41 million.
- 74.23% is the calculated decline from the 52-week high of USD 3.88 to the indicated price, against a 52-week low of USD 0.434 that defines the range for Ainos shares.
What Moved Ainos, Inc. (NASDAQ:AIMD) in Pre-Market Trading on November 17, 2026 (-USD 0.1456, -12.71%)
Ainos, Inc. (NASDAQ:AIMD) is indicated at USD 1.00 in pre-market trading on Tuesday, November 17, 2026, a pre-market move of -12.71%. The calculated prior close is USD 1.1456 (price divided by 0.8729) and the calculated USD move is -USD 0.1456. With 7.38 million shares outstanding, the calculated market capitalization is about USD 7.38 million.
The Rationale: Third Quarter Results and the USD 9 Million ASE Purchase Agreement for Ainos, Inc. (NASDAQ:AIMD)
The company released third quarter 2026 results on November 16, 2026, reporting revenue of USD 642,889 against USD 2,167 a year earlier. Chairman and Chief Executive Officer Eddy Tsai said the results show progress in translating commercial agreements into revenue. On November 12, 2026 the company announced a USD 9 million purchase agreement with ASE Technology Holding Co., Ltd. for 5,000 additional AI Nose systems, its largest single order, about 4.3 times the earlier USD 2.1 million agreement under which 1,400 systems were delivered. A 50% deposit of USD 4.5 million is due within 60 days of signing, with the balance payable after delivery. No explanation for the pre-market decline was identified in published coverage, so the direction of the move is not attributed to these events.
Valuation, Liquidity and Risks for Ainos, Inc. (NASDAQ:AIMD)
Trailing revenue is USD 654,322, up 478.9%, against a trailing net loss of USD 13.41 million, or USD 1.78 per share. Cash and Debt figures were not found. On September 24, 2026 the company signed a VELDONA license agreement with BioPhoenix with a potential USD 10 million collaboration framework, and on September 30, 2026 it completed the technology transfer, triggering a USD 600,000 license payment. With a calculated Market Value under USD 100 million, this is a nano-cap with elevated dilution and Volatility risk.
Where Things Stand
The indicated pre-market price of USD 1.00 for Ainos, Inc. (NASDAQ:AIMD) is 12.71% below a calculated prior close of USD 1.1456 on November 17, 2026. The company has about 7.38 million shares, a calculated market value near USD 7.38 million, third quarter revenue of USD 642,889 and a trailing net loss of USD 13.41 million. The November 12, 2026 USD 9 million ASE agreement and the November 16, 2026 results are the most recent company events found, though neither explains the direction of the move. Low-priced volatility and thin liquidity are general context rather than established causes. Pre-market quotes are indicative until the 9:30 a.m. ET open.






Please wait processing your request...